Daxor
16 hedge funds and large institutions have $4.48M invested in Daxor in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 1 closing their positions.
78,718% more capital inflows, than outflows
Capital inflows: $4.54M | Capital outflows: $5.76K
700% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 1
60% more funds holding
Funds holding: 10 → 16 (+6)
6.3% more ownership
Funds ownership: 2.88% → 9.19% (+6.3%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thompson Siegel & Walmsley
Richmond,
Virginia
|
+$2.83M |
| 2 |
Aristides Capital
Louisville,
Kentucky
|
+$508K |
| 3 |
Empirical Wealth Management
Seattle,
Washington
|
+$307K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$167K |
| 5 |
Crescent Grove Advisors
Lake Forest,
Illinois
|
+$131K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$2.56K |
| 2 |
Morgan Stanley
New York
|
-$1.83K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.33K |
| 4 |
JP Morgan Chase
New York
|
-$49 |
DXR Hedge Fund Activity: Q1 2026 in Review
16 of the 8,232 institutional investors tracked by Wall St. Rank reported a position in Daxor (DXR) for Q1 2026, worth a combined $4.48M — up 118% from $2.06M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new DXR positions and 1 closed out — a net gain of 7 holders — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Thompson Siegel & Walmsley, opening a new position worth an estimated $2.83M. The largest seller was Renaissance Technologies, cutting an estimated $2.56K.
- 16 institutional investors held Daxor (DXR) as of Q1 2026, up from 10 in Q4 2025.
- Funds reported $4.48M of Daxor stock for Q1 2026, up 118% quarter-over-quarter.
- 8 funds opened new Daxor positions in Q1 2026 and 1 closed out, a net change of +7 holders.
- The largest Daxor buyer in Q1 2026 was Thompson Siegel & Walmsley, an estimated $2.83M added.
- The largest Daxor seller in Q1 2026 was Renaissance Technologies, an estimated $2.56K sold.
Based on aggregated 13F filings for Q1 2026.